The panel / The causes nobody else checks

A1c and fasting glucose

This is the test most likely to find something you did not come in for. Metabolic disease is usually silent for years, it suppresses testosterone through a mechanism that is reversible, and about a third of men with type 2 diabetes are running low testosterone as a consequence.

What it measures

A1c reflects your average blood sugar over roughly the preceding two to three months, by measuring how much glucose has attached to your red cells. Fasting glucose is a single point in time. They answer slightly different questions, which is why both are drawn rather than one.

A1c is a two to three month average, not a snapshot

Fasting glucose is a single reading and moves day to day

Diagnosis requires two abnormal results unless symptoms are unmistakable

A1c assumes your red cells live a normal lifespan. Anything that changes red cell turnover changes the result without your blood sugar changing at all, which is the main way this test misleads.

How it is measured

SpecimenSerum and whole blood

TimingMorning, with the panel

FastingRequired for the fasting glucose

ConfirmationTwo abnormal results before a diagnosis

If A1c is unreliableConfirm with a glucose-based test

TurnaroundTypically 1 to 3 days

Why it is on the panel

Both are drawn on every patient, and this is the test most likely to find something you did not come in for. The relationship with testosterone runs in both directions and one of those directions is fixable. Type 2 diabetes and the obesity that usually accompanies it suppress the signal from the brain to the testicles, producing a secondary pattern. Because there is no structural damage to the axis, that is frequently reversible with weight loss and better glucose control. Going the other way, a low testosterone predicts developing diabetes later, which makes this a screening opportunity as much as a diagnostic one.

Interpretation

Reading the result

These are the American Diabetes Association thresholds.

Bands used in practice

A1c under 5.7, glucose under 100Normal.

A1c 5.7 to 6.4, glucose 100 to 125Prediabetes. The stage where change still reverses it.

A1c 6.5 or above, glucose 126 or aboveType 2 diabetes, confirmed on a second result.

Low SHBG with normal glucoseOften the earliest signal, before A1c has moved at all.

Around a third of men with type 2 diabetes have low total testosterone, with more recent estimates spanning roughly 25 to 40 percent. But a large share of that is a low SHBG dragging the total down while free testosterone stays normal, which is not deficiency and should not be treated as such.

What makes A1c unreliable

In any of these, the glucose-based tests carry more weight than the A1c.

6 things that move it

Iron deficiency, haemolytic anaemia, and any condition altering red cell lifespan.

Recent blood transfusion, or treatment with erythropoiesis-stimulating agents.

Advanced kidney disease and haemodialysis.

Haemoglobin variants including sickle cell trait, depending on the assay used.

G6PD deficiency, where the G202A variant lowers A1c by roughly 0.7 to 0.8 percent in homozygotes.

Ethnic variation. Black patients tend to run A1c about 0.3 percent higher at equivalent blood sugar, which raises the risk of a false prediabetes label.

What happens next

Prediabetes is treated as the opportunity it is, because this is the stage where weight, activity and sleep still reverse the trajectory.

Where a secondary testosterone pattern sits alongside metabolic disease, the metabolic disease is addressed first. Weight loss of even 5 percent often raises testosterone meaningfully.

Free testosterone is used rather than total, because low SHBG in insulin resistance makes the total misleading.

A total testosterone below 150 is not attributed to diabetes. That is uncommon in this setting and prompts a proper workup for pituitary or testicular disease.

Straight answers

On the evidence, no. Meta-analysis of randomised trials in men with type 2 diabetes and metabolic syndrome found no improvement in A1c with testosterone therapy, and guidelines do not endorse it for glycaemic or cardiometabolic benefit. Testosterone is prescribed for symptoms of deficiency when deficiency is real. It is not a diabetes treatment, whatever you may have read.